Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Effects of Clarithromycin Administration on Gastric Acid Secretion and Cytoprotection in Wistar Rats
N E Ezomike1, U O Ezomike2, Eme E Osim3
1. elsienk2013@gmail.com.
Clarithromycin (CLX) significantly reduced gastric ulcers in rats by increasing gastric mucus secretion, not just its antibiotic properties. This finding suggests CLX offers a dual protective mechanism against peptic ulcer disease.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Peptic ulcer disease affects 28% of Nigerians.
- Clarithromycin (CLX) is used for peptic ulcers due to its antibacterial action.
- CLX's effects on other gastrointestinal parameters are not well-understood.
Purpose of the Study:
- To investigate the effects of CLX on gastric acid secretion.
- To determine CLX's impact on mucus secretion.
- To evaluate CLX's influence on gastric ulcer scores in rats.
Main Methods:
- 30 albino Wistar rats were divided into test (CLX-treated) and control groups.
- Standard methods assessed gastric acid secretion, mucus secretion, and ulcer scores.
- CLX was administered orally to test groups.
Main Results:
- CLX significantly increased basal gastric acid and peak acid output (p<0.001).
- Mucus secretion was significantly elevated in CLX-treated rats (p<0.001).
- Gastric ulcer scores were significantly reduced in CLX-treated rats (p<0.001).
Conclusions:
- Clarithromycin administration effectively reduced gastric ulcers in a rat model.
- CLX's protective effect may stem from increased gastric mucus production, counteracting acid's aggressive action.
- This suggests a mechanism beyond antibiotic properties for CLX in peptic ulcer treatment.
More Related Videos
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

